APA

Larrayoz M., Rose-Zerilli M. J. J., Kadalayil L., Parker H., Blakemore S., Forster J., Davis Z., Steele A. J., Collins A., Else M., Catovsky D., Oscier D. G. & Strefford J. C. (20170925). Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial. : Leukemia.

Chicago

Larrayoz M, Rose-Zerilli M J J, Kadalayil L, Parker H, Blakemore S, Forster J, Davis Z, Steele A J, Collins A, Else M, Catovsky D, Oscier D G and Strefford J C. 20170925. Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial. : Leukemia.

Harvard

Larrayoz M., Rose-Zerilli M. J. J., Kadalayil L., Parker H., Blakemore S., Forster J., Davis Z., Steele A. J., Collins A., Else M., Catovsky D., Oscier D. G. and Strefford J. C. (20170925). Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial. : Leukemia.

MLA

Larrayoz M, Rose-Zerilli M J J, Kadalayil L, Parker H, Blakemore S, Forster J, Davis Z, Steele A J, Collins A, Else M, Catovsky D, Oscier D G and Strefford J C. Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial. : Leukemia. 20170925.